Loading clinical trials...
Loading clinical trials...
Ex vivo expanded human myeloid progenitor cells (hMPCs; CLT-008) have the potential to accelerate neutrophil recovery in patients receiving myeloablative conditioning as part of an umbilical cord bloo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cellerant Therapeutics
Collaborators
NCT06191978 · Acute Myeloid Leukemia
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT06317649 · Acute Myeloid Leukemia
NCT07053436 · High Risk Newly Diagnosed Multiple Myeloma
NCT06311227 · Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant
Children's Hospital of Orange County
Orange, California
Alfred I. duPont Hospital for Children
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions